VCANBIO plans to acquire a 25% stake in Shanghai Zhongyuan Jisheng Company
I'm PortAI, I can summarize articles.
VCANBIO announced plans to acquire a 25% stake in Shanghai Zhongyuan Jisheng Company for a transaction price of 3.8196 million yuan. This move aims to improve operational decision-making efficiency and increase resource investment in the adult health cell storage business. Upon completion of the transaction, Shanghai Zhongyuan Jisheng Company will become a wholly-owned subsidiary of VCANBIO, promoting the collaborative development of various business segments and building a complete business closed loop
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments